Superworth

Diagnostics and research stocks with the fastest expected revenue growth

Analysts' consensus revenue for the next four quarters against the last four reported. As of .

Ranked
11
of 74 diagnostics and research stocks we cover
Median
+6.7%
Highest
+48.3%
WAT
Range
+4.7% to +48.3%
median +6.7%
+4.7%+48.3%
#CompanyExpected growthRevenue growth (TTM)Forward PEMarket cap
1WATWaters+48.3%+52.5%30.4×$46.4B
2GHGuardant Health+31.1%+42.7%n/m$23.7B
3NTRANatera+15.6%+37.8%n/m$56.2B
4DHRDanaher+8.9%+5.5%25.4×$162.6B
5IDXXIDEXX Laboratories+7.6%+12.8%42.4×$52.1B
6AAgilent Technologies+6.7%+8.6%26.8×$49.6B
7ILMNIllumina+5.6%+4.9%41.5×$35.7B
8IQVIQVIA+5.5%+8.2%19.0×$42.5B
9LHLabcorp+5.2%+6.4%18.8×$28.9B
10TMOThermo Fisher Scientific+5.0%+8.3%25.8×$256.9B
11MTDMettler-Toledo International+4.7%+6.9%34.6×$34.2B

Not ranked: 60 with not a meaningful number. 3 companies whose data behind this number has a caveat are left out until it is checked.

A ranking of numbers, not a recommendation. A low multiple can be a bargain or a business in trouble: open the company to see which.

Expected growth for other groups

Other rankings of diagnostics and research stocks

The group